A Supreme Court decision against drug developers in Sorrell v. IMS Health could potentially hamper how pharmacy benefit managers can use physician prescription data to drive adoption of pharmacogenomically guided products.
In a filing with the federal appeals court, the DoJ attempted to strike a balance between rewarding inventions that result from genomic discoveries and ensuring that discoveries of natural phenomena remain in the "storehouse of knowledge of all men." Meanwhile, it's business as usual at the USPTO until the appeals court rules on Myriad's challenged BRCA patents.
A report issued by Battelle Memorial Foundation and the Biotechnology Industry Organization has found that job creation by US life sciences employers survived the first year of the recession in 2008, and thrived over most of the previous two years. However, the report also showed a decline in bioscience-related patents among the top 10 states in that category.